IVERMECTIN & FENBENDAZOLE
What They Called "Horse Dewormer" Won a Nobel Prize
What They Ignored Reversed Terminal Cancer
TWO DRUGS. UNDER $1 A DOSE. DECADES OF SAFETY DATA. SYSTEMATICALLY SUPPRESSED.
⚠ DISCLAIMER: This page is for informational purposes only. Nothing here is medical advice. Research every claim independently. Links to primary sources are provided throughout. We are not doctors — we are people who read and ask questions the system discourages.
// IVERMECTIN — NOBEL PRIZE 2015 // HORSE DEWORMER NARRATIVE — 2020 // COURT RULES FDA OVERSTEPPED — 2023 // FOLLOW THE MONEY //
The same drug that won the Nobel Prize in Medicine in 2015 for its "extraordinary impact on global health" — given free to over 4 billion people — was rebranded as a dangerous horse dewormer in 2020 when it threatened billions in pharmaceutical revenue. That rebranding was not accidental. It was strategy.
IVERMECTIN
Stromectol (human) / Soolantra (topical) / Ivomec (vet)
Discovered 1975 by Satoshi Omura. Nobel Prize in Medicine 2015. Called a "wonder drug" by the WHO. Given free to hundreds of millions across Africa and Asia for river blindness and lymphatic filariasis. Universally praised — until 2020.
- Parasites (approved) — roundworms, pinworms, strongyloides, scabies, head lice, river blindness. Original and FDA-approved use. Extraordinary safety record over 50 years.
- Antiviral mechanism — inhibits importin alpha/beta nuclear transport proteins that RNA viruses depend on to replicate. Demonstrated in vitro against SARS-CoV-2, dengue, Zika, HIV, and others.
- COVID-19 — 63 studies, 31 randomized controlled trials. Meta-analyses at ivmmeta.com show consistent benefit in early treatment and prevention. Suppressed aggressively while $3,000/course Paxlovid received emergency authorization.
- Cancer — induces apoptosis in cancer cells. Inhibits Wnt/beta-catenin signaling (active in many cancers). Research ongoing in glioblastoma, breast, colon, and ovarian cancers.
- Rosacea / Demodex mites — topical ivermectin (Soolantra) is FDA approved for rosacea. Demodex mite overgrowth is a documented driver of multiple skin conditions. Generic compounded version available at fraction of the brand cost.
- Yearly parasite cleanse — 0.2mg/kg single dose clears most common intestinal parasites. Many people do this annually. Telehealth providers will prescribe for parasite prevention.
FDA APPROVED (PARASITES)
OFF-LABEL (ANTIVIRAL)
RESEARCH (CANCER)
SUPPRESSED (COVID)
NOBEL PRIZE 2015
FENBENDAZOLE
Panacur / Safe-Guard (vet) — No human brand name. That's intentional.
Veterinary antiparasitic developed in the 1970s. Prescribed to dogs, cats, horses, cattle for 50 years. Zero significant side effects at standard doses. Joe Tippens' 2017 terminal cancer remission — credited publicly to fenbendazole — ignited research globally, especially South Korea.
- Veterinary parasites (approved) — roundworms, hookworms, whipworms, tapeworms, giardia in dogs, cats, horses, cattle. 50 years of safety data across millions of animals.
- Cancer — tubulin disruption — binds beta-tubulin in cancer cells and prevents mitotic spindle formation. Cancer cells cannot divide. Same mechanism as taxane chemotherapy drugs — but at a fraction of the toxicity and cost.
- Cancer — glucose starvation — disrupts GLUT glucose transporters. Cancer cells rely overwhelmingly on glucose fermentation (the Warburg effect). Fenbendazole cuts off their fuel supply.
- Cancer — p53 reactivation — reactivates the p53 tumor suppressor gene, which is mutated or silenced in over 50% of all human cancers. p53 is often called "the guardian of the genome."
- Antiparasitic (human, off-label) — the Joe Tippens Protocol brought fenbendazole into the mainstream conversation. Thousands worldwide now use it for parasite clearance and cancer support.
- Antifungal — emerging evidence of activity against Candida overgrowth and other fungal infections through similar tubulin-disruption mechanism.
VET APPROVED (PARASITES)
OFF-LABEL (HUMAN)
ACTIVE RESEARCH (CANCER)
JOE TIPPENS PROTOCOL
TERMINAL CANCER. 3 MONTHS TO LIVE. $5/WEEK DOG DEWORMER. COMPLETE REMISSION.
In 2016, Joe Tippens was diagnosed with small cell lung cancer that had spread throughout his entire body — lungs, stomach, bladder, pancreas, neck. His oncologist gave him 3 months to live. He enrolled in a clinical trial but was told the cancer was progressing despite treatment.
A veterinarian friend mentioned that researchers had accidentally discovered fenbendazole — a common dog dewormer — appeared to prevent cancer cells from consuming glucose. Tippens had nothing to lose. He started taking Panacur C ($5/week at Walmart) along with vitamin E succinate (800mg), full-spectrum CBD oil, and curcumin (600mg). He continued the clinical trial drug in parallel.
Three months later, a full-body PET scan showed no evidence of cancer anywhere in his body. His oncologist called it "unexplainable." The clinical trial drug had a 4% success rate. Tippens was the only patient in his group who responded. The difference between him and the others was the fenbendazole protocol.
"They told me I had 3 months. I'm still here. All I did was add a dog dewormer. I'm not telling anyone to do what I did. I'm telling everyone to ask why nobody studied this for 50 years."
His story went viral. South Korean oncologists took it seriously when American medicine wouldn't. They ran the studies. The results confirmed the mechanism. Thousands of cancer patients globally — particularly in South Korea, India, and parts of Europe — began using fenbendazole as an adjunct to conventional treatment.
His original blog: mycancerstory.rocks • The community he built: myfenbendazole.com
FENBENDAZOLE & IVERMECTIN — HOW THEY ATTACK CANCER CELLS
These are not fringe theories. These are published, peer-reviewed mechanisms documented in labs at Johns Hopkins, MD Anderson, and universities across South Korea, India, and Europe. The research exists. It simply does not receive the funding, attention, or clinical trial support that a patented $30,000/course drug would receive.
Both compounds attack cancer through multiple pathways simultaneously — which is actually more sophisticated than many single-target chemotherapy drugs. Cancer's ability to mutate around a single-pathway drug is well documented. Multi-pathway attack is harder to evade.
Tubulin disruption → cell division stopped
Glucose starvation → Warburg effect blocked
p53 reactivation → tumor suppressor restored
Apoptosis induction → cancer cell self-destruction triggered
Angiogenesis inhibition → tumor blood supply cut
Wnt/beta-catenin inhibition → cancer stem cell pathway blocked
NK cell activation → immune attack on tumor enhanced
MDR reversal → drug-resistant cancers may respond
Cancer treatment is a $200 billion/year industry. A drug that costs $1/day and attacks cancer through 6 simultaneous mechanisms — with 50 years of safety data — is not an opportunity for that industry. It is a threat.
2015
Nobel Prize — Ivermectin
Satoshi Omura and William Campbell win Nobel Prize in Medicine. WHO calls ivermectin an essential medicine. Universally celebrated. Zero controversy.
2017
Joe Tippens goes public
Terminal cancer patient credits dog dewormer for complete remission. Story spreads. South Korean oncologists begin systematic investigation. Thousands begin self-treating globally.
2020 — March
COVID emergency declared
Under US law, Emergency Use Authorization cannot be granted if an adequate approved treatment already exists. The financial stakes for new drugs and vaccines: hundreds of billions of dollars.
2020 — April
Ivermectin shows COVID activity
Australian study shows ivermectin reduces SARS-CoV-2 replication by 99.8% in vitro. Front line doctors begin reporting positive outcomes. Studies begin globally.
2020-2021
"Horse dewormer" narrative launched
FDA, CDC, and media simultaneously pivot to "horse dewormer" framing. The drug that won a Nobel Prize for its human medical impact is rebranded as dangerous livestock medication. The campaign is coordinated and effective.
2021 — June
Merck statement against ivermectin
Merck — the company that invented ivermectin and donated billions of doses free — issues statement saying no scientific basis exists for COVID use. Merck simultaneously had molnupiravir ($700/course) in late-stage development. No conflict of interest declared.
2021-2022
Doctors lose licenses
Board-certified physicians sanctioned, suspended, and fired for prescribing an FDA-approved drug off-label — a standard and legal medical practice. Pharmacies refuse to fill valid prescriptions. Medical boards weaponized.
2023
Federal court rules FDA overstepped
5th Circuit Court rules FDA exceeded its authority by advising against ivermectin. FDA quietly removes "stop it" social media posts. No apology. No retraction. No reinstatement of sanctioned doctors. The damage was done.
2023-2024
Fenbendazole cancer trials published
South Korean research community publishes multiple peer-reviewed studies confirming anticancer activity. Johns Hopkins independently confirms beta-tubulin binding mechanism. Major US cancer institutions remain silent.
Ongoing
Both remain accessible — barely
Ivermectin via telehealth providers and compounding pharmacies. Fenbendazole sold openly as Panacur/Safe-Guard at farm supply stores. The information suppression continues even as the drugs remain technically legal to obtain.
PATENT EXPIRATION = ZERO PROFIT MOTIVE
Both compounds are decades old and off-patent. Any manufacturer can produce them. A drug no single company owns exclusively will never receive the institutional support, research funding, or media coverage that a patent-protected drug commands — regardless of how well it works. The incentive structure of pharmaceutical development does not reward cheap solutions.
EMERGENCY USE AUTHORIZATION REQUIRED NO APPROVED ALTERNATIVE
Under 21 U.S.C. 360bbb-3, an Emergency Use Authorization cannot be maintained if an adequate approved treatment already exists. If ivermectin was officially acknowledged as effective against COVID-19, the EUA for vaccines — and the billions in revenue attached to it — could not legally stand. This is not a theory. It is the statute. Read it yourself.
CANCER TREATMENT IS A $200 BILLION INDUSTRY
A single course of chemotherapy can run $10,000-$100,000. Targeted cancer drugs can cost $300,000/year. Fenbendazole costs $5/week. If a veterinary antiparasitic disrupts tumor metabolism through six simultaneous mechanisms with a 50-year safety record, and that becomes accepted practice — entire revenue streams evaporate. The financial incentive to suppress is not subtle. It is structural.
THE "HORSE DEWORMER" CAMPAIGN WAS DELIBERATE STRATEGY
Ivermectin has a dedicated human formulation. It has been given to over 4 billion human beings. It won the highest prize in medicine for its impact on human health. Calling it a "horse dewormer" was not a mistake or an oversimplification. It was a calculated messaging strategy designed to trigger ridicule and end the conversation. It worked. Most Americans still believe it.
The FLCCC Alliance (Front Line COVID-19 Critical Care Alliance) is an organization of board-certified ICU physicians and medical scientists who documented patient outcomes and published treatment protocols using ivermectin. They are not fringe figures. They are credentialed professionals who followed the data where it led and were punished for it. Their full protocol library is at covid19criticalcare.com.
| USE CASE |
DRUG |
TYPICAL PROTOCOL |
NOTES |
| Yearly parasite cleanse |
Ivermectin |
0.2mg/kg body weight. Single dose or 2 doses 2 weeks apart. Take on empty stomach. |
Standard antiparasitic dosing well within established safety range. Telehealth providers (e.g. GETivermectin.com, pushhealth.com) will prescribe for parasite prevention. No emergency room visit for "horse dewormer" has ever been documented from properly dosed human ivermectin. |
| Parasite cleanse — OTC |
Fenbendazole |
222mg/day for 3 consecutive days on, 4 days off. Repeat 2-3 cycles. Take with a fatty meal for absorption. |
Panacur C (dog dewormer — 1g packets, 222mg fenbendazole each) available at Tractor Supply, Farm & Fleet, Chewy, Amazon. No prescription needed. This is exactly the base of the Joe Tippens Protocol. Widely used. |
| Joe Tippens Cancer Protocol |
Fenbendazole |
222mg fenbendazole daily (Mon/Wed/Fri or daily). + Vitamin E succinate 800mg. + Full spectrum CBD oil. + Curcumin 600mg. With a fatty meal. |
Used by thousands globally as an adjunct to conventional treatment — not as a replacement. The myfenbendazole.com community documents individual cases. Always disclose to your oncologist. Some are aware of the research and supportive. Some are not. |
| Skin / Rosacea / Demodex |
Ivermectin |
Topical 1% cream applied to face nightly. FDA-approved as Soolantra. Generic version at compounding pharmacies. Or oral 12mg single dose repeated in 2 weeks for systemic Demodex. |
Soolantra (brand) is expensive. Compounded topical ivermectin 1% is identical and a fraction of the cost. Ask a compounding pharmacy. Many dermatologists prescribe it once they understand the Demodex connection. |
| Early illness / antiviral |
Ivermectin |
0.2-0.4mg/kg at first sign of illness. Repeat on day 2 and day 5 for moderate symptoms. Full FLCCC protocol at covid19criticalcare.com. |
FLCCC I-CARE protocol is publicly available and regularly updated. Written by ICU physicians. Based on documented patient outcomes from multiple countries and continents. Read it yourself and make your own decision. |
Neither of these drugs is a magic bullet. Neither is a guaranteed cure for anything beyond their approved indications. What they are: cheap, safe, off-patent compounds with real research behind uses that threaten profitable alternatives — and that is why the conversation about them has been aggressively controlled. Ask why. That question alone is worth something.
In 2015 the world celebrated ivermectin with a Nobel Prize. In 2020 the world mocked people for taking it. Nothing about the drug changed. Everything about the financial stakes did.